Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies. | Front Immunol | 2022 | 35958562 | PubTator, text mining | PubMed |
| Biomolecular Corona Stability in Association with Plasma Cholesterol Level. | Nanomaterials (Basel) | 2022 | 35957093 | PubTator, text mining | PubMed |
| Polymorphisms of the 11q23.3 Locus Affect the Risk and Mortality of Coronary Artery Disease. | J Clin Med | 2022 | 35956147 | PubTator, text mining | PubMed |
| Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular Aging. | Int J Mol Sci | 2022 | 35955804 | PubTator, text mining | PubMed |
| Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer. | Cancers (Basel) | 2022 | 35954383 | PubTator, text mining | PubMed |
| Translational Medicine and Implementation Science: How to Transform What We Know Into What We Do. | Arq Bras Cardiol | 2022 | 35946696 | PubTator, text mining | PubMed |
| Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy. | BMC Cancer | 2022 | 35945555 | PubTator, text mining | PubMed |
| Asymmetric depth-filtration: A versatile and scalable method for high-yield isolation of extracellular vesicles with low contamination. | J Extracell Vesicles | 2022 | 35942823 | PubTator, text mining | PubMed |
| Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning. | Mol Cell Proteomics | 2022 | 35931319 | PubTator, text mining | PubMed |
| The involvement of gut microbiota in the anti-tumor effect of carnosic acid via IL-17 suppression in colorectal cancer. | Chem Biol Interact | 2022 | 35926579 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort. | Haematologica | 2022 | 35924579 | PubTator, text mining | PubMed |
| Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers. | J Mol Med (Berl) | 2022 | 35915349 | PubTator, text mining | PubMed |
| Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features. | Cell Death Dis | 2022 | 35915082 | PubTator, text mining | PubMed |
| Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis. | PLoS One | 2022 | 35913946 | PubTator, text mining | PubMed |
| Apolipoprotein A4 Restricts Diet-Induced Hepatic Steatosis via SREBF1-Mediated Lipogenesis and Enhances IRS-PI3K-Akt Signaling. | Mol Nutr Food Res | 2022 | 35909347 | PubTator, text mining | PubMed |
| Unbiased proteomic analysis of extracellular vesicles secreted by senescent human vascular smooth muscle cells reveals their ability to modulate immune cell functions. | Geroscience | 2022 | 35900662 | PubTator, text mining | PubMed |
| A unique dysregulation pattern of lipid metabolism and immune responses in patients with omicron SARS-CoV-2 recurrence. | QJM | 2022 | 35900155 | PubTator, text mining | PubMed |
| Metabolic Action of Metformin. | Pharmaceuticals (Basel) | 2022 | 35890109 | PubTator, text mining | PubMed |
| Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning. | Int J Mol Sci | 2022 | 35887259 | PubTator, text mining | PubMed |
| Stage II of Chronic Kidney Disease-A Tipping Point in Disease Progression? | Biomedicines | 2022 | 35884827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=27